AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05922293 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: blow bottle
Description: When you blow through a tube into water in a bottle, the pressure in the airways increases. This opens up the passageways between bronchioles, allowing air to flow behind the mucus and push it into the larger airways. This way, it will be easy to remove the mucus by coughing or huffing.
Study NCT05922293 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blow bottle
Description: When you blow through a tube into water in a bottle, the pressure in the airways increases. This opens up the passageways between bronchioles, allowing air to flow behind the mucus and push it into the larger airways. This way, it will be easy to remove the mucus by coughing or huffing.
Study NCT05922293 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: percussion
Description: Percussion technique should be performed for about 30 seconds and simultaneously with no more than three or four lower thoracic expansion exercises.~* Do this for a total of 10 breaths,~* Perform two huffs, and~* Cough.~* Close their mouth around the tube and exhale slightly forcefully for 3 seconds to produce bubbles. Such exhalations were conducted in two sets of ten, with a five-minute pause in between. For each subject, a fresh, disposable tube and bottle were utilized
Study NCT06253598 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant Human Adenovirus Type 5
Description: Recombinant Human Adenovirus Type 5( H101 )was administered intratumorally on day 1 and 5 of cycle 1 and cycle 2. If the sum of the maximum diameters of the lesions was less than or equal to 10 cm, the total dose was 1.0×10\^12 vp . If the sum of the maximum diameters of the lesions was more than 10 cm, the total dose was 1.5×10\^12 vp. Recombinant Human Adenovirus Type 5 was diluted to 30% of the total tumor volume with normal saline before administration. Under the guidance of ultrasound, percutaneous puncture was performed to the center of the tumor, and the solution was uniformly injected into the tumor. If there are multiple lesions, the distribution of each lesion should be proportional to the size of the tumor. No more than 5 lesions.
Study NCT06253598 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Lenvatinib was administered orally once daily started on day 1 of cycle 1 of the study until disease progression or unacceptable toxicity occurred or meet the end point of the study. For patients weighing less than 60 kg, the recommended daily dose was 8 mg once daily. For patients weighing ≥60 kg, the recommended daily dose was 12 mg once daily
Study NCT06253598 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: Tislelizumab 200mg was administered intravenously every 3 week started on day 1 of cycle 3 until disease progression or unacceptable toxicity occurred or meet the end point of the study.
Study NCT04672226 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: PDE MAX
Description: PDE MAX will be prescribed by the study dietitian based on the patient's individual requirement.
Study NCT06603909 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: group 1: Use AI to assist nutrition management
Description: group1：AI-assisted nutrition management. group 2：Traditional nutrition management（through the hospital dietitian）.group 3:control.
Study NCT06603909 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: group 2：Traditional nutrition management（through the hospital dietitian）
Description: group 2：Traditional nutrition management（through the hospital dietitian）
Study NCT06604611 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine 0.5 MG Oral Tablet Once Daily
Description: The intervention in this study is colchicine, patients randomized to the experimental group will be given oral colchicine 5mg once a day in 12 weeks.
Study NCT06597045 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PET/CT with 18-FDG
Description: Study specific tests will include 18F-FDG PET/CT (specialised CT scan), electrocardiography (ECG), clinic blood pressure assessment, blood tests, urine sample, echocardiography (heart ultrasound) and tests on the fingertips (EndoPAT).~Positron emission tomography with computerised tomography (PET-CT) is a scanning technique in routine clinical use. It is the gold standard method for assessing blood vessel inflammation. A small amount of radioactive sugar (18F-FDG \[18F- fluorodeoxyglucose\]) is administered intravenously 90 minutes prior to the PET-CT scan. The distribution of uptake of this tracer is seen on the subsequent PET-CT scan. The CT component of this scan allows the PET image to be precisely aligned with anatomical structures (especially large blood vessels).
Study NCT06587711 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: acupuncture treatment
Description: Patients in experimental group received acupuncture at specific acupoint on the face, patients in control group received sham acupuncture at non-acupoint on the face.
Study NCT06587711 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: acupuncture treatment
Description: Patients in experimental group received acupuncture at specific acupoint on the face, patients in control group received sham acupuncture at non-acupoint on the face.
Study NCT06601088 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation
Description: Patients will be instructed to apply the wearable NMES-therapy continuously, both day and night at least 10h/daily.
Study NCT06592651 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Play Therapy Workshop
Description: 4 session group intervention foucused on psycho-educational knowledge regarding tools for effective emotional coping with stressful events in the context of the Iron Swords war, focusing on building mental resilience in the parent-child dyad through play therapy. Each group consists of 5 parent-child dyads with children aged 3-6 years, who have been evacuated from war zones in the northern and southern regions of the country.
Study NCT05652010 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: New 2-piece Coupling
Description: Flat or concave baseplate. SenSura Mio Click maxi bag (open, wide outlet) with new 50mm Ø coupling.
Study NCT05652010 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SenSura Mio Click
Description: Flat or concave baseplate. SenSura Mio Click maxi bag (open, wide outlet) with 50mm Ø coupling.
Study NCT06593821 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Occlusal splint
Description: The occlusal splint was fabricated from a 2 mm hard splinting resin material on the plaster model obtained by taking impressions of the patients\&amp;#39; upper jaw.
Study NCT06593821 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: preventive advice
Description: Control group given protective advice such as supporting the jaw when yawning, not chewing gum, not opening the mouth for too long and not opening it too wide, and chewing on both sides when eating.
Study NCT06593821 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Botulinum toxin
Description: A total of 50 U of botulinum toxin, 25 U in each muscle, was injected
Study NCT06600659 — intervention group
Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-interventional study
Study NCT06369909 — intervention group
Intervention type: PROCEDURE
Intervention: EUS-FNA
Description: For patients with pancreatic masses, EUS-FNA is performed to confirm pathological diagnosis, and pancreatic biopsy samples and duodenal mucosal biopsy samples are collected.
Study NCT06601530 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transversus Thoracic Muscle Plane Block
Description: Transversus thoracic muscle plane block is a single-shot nerve block technique that provides analgesia for the anterior chest wall Tramadol IV PCA (Patient Controlled Analgesia): Basal infusion 0.2 mg/kg/h, bolus 20 mg, lock time 20 minutes
Study NCT06601530 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tramadol
Description: Tramadol IV PCA (Patient Controlled Analgesia): Basal infusion 0.2 mg/kg/h, bolus 20 mg, lock time 20 minutes
Study NCT06601530 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: Tramadol IV PCA (Patient Controlled Analgesia): Basal infusion 0.2 mg/kg/h, bolus 20 mg, lock time 20 minutes
Study NCT06527794 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RHYTHM (Remote Hypertension Tracking Help Management)
Description: Home blood pressure telemonitoring with remote medication management by a centralized multidisciplinary team led by a pharmacist; and social support, lifestyle education and connection to community resources to address social needs, provided by a community health worker who is embedded with the centralized team and is tightly connected to community resources and partners
Study NCT06527794 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced usual care (UC)
Description: All participating sites will receive training on appropriate blood pressure measurement and education on guideline-based hypertension therapy. Additionally, participants in usual care will receive a standardized packet with evidence-based hypertension education material and a blood pressure monitor to complete blood pressure measurements at home.
Study NCT06600230 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education and exercise
Description: Training including information on pelvic floor and dysmenorrhea and exercise practices were given both theoretically and practically by physiotherapists.
Study NCT06600230 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Self-method like resting or heat
Description: Classical self-methods such as rest and heat application were applied.
Study NCT06589739 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Headset
Description: A virtual reality headset will be placed on patients\&#39; head before and during chest drain insertion
Study NCT06591494 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Classic quadruple therapy
Description: Esomeprazole 20 mg BID Bismuth pectin 200 mg BID Amoxicillin 1 g BID Clarithromycin 500 mg BID
Study NCT06591494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Quadruple therapy with sodium bicarbonate instead of bismuth
Description: Esomeprazole 20 mg BID Sodium bicarbonate 500 mg TID Amoxicillin 1 g BID Clarithromycin 500 mg BID
Study NCT06591494 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Quadruple therapy with sodium bicarbonate instead of clarithromycin
Description: Esomeprazole 20 mg BID Bismuth pectin 200 mg BID Amoxicillin 1 g BID Sodium bicarbonate 500 mg TID
Study NCT06592482 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0780
Description: A single A dose of AZD0780 will be administered in the morning on Day 1 under fasted condition. Study intervention will be administered orally with approximately 240 mL of water.
Study NCT06602661 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fissureless Lobectomy with Reinforced Staple Lines
Description: This intervention involves performing a fissureless lobectomy, a type of lung surgery where the lobes of the lung are removed without dissecting the fissures between them. The procedure utilizes the ECHELON™ 3000 stapler equipped with the ENDOPATH™ stapler line reinforcement. The ENDOPATH™ device uses bioabsorbable buttress material made from Polyglactin and Polydioxanone, designed to enhance the durability and effectiveness of the staple line.~The reinforcement tool is a novel preloaded device with a click and go mechanism, making it easy to load and use during surgery.~The primary objective is to reduce the average duration of hospital length of stay (LOS) directly caused by prolonged air leak (PAL). Secondary objectives include improving intraoperative characteristics (such as duration and amount of blood loss) and postoperative outcomes (such as incidence and duration of PALs, number of chest tube days, and incidence of hospital.
Study NCT06602661 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Fissureless Lobectomy with Non-Reinforced Staple Lines
Description: This intervention involves performing a fissureless lobectomy, a type of lung surgery where the lobes of the lung are removed without dissecting the fissures between them. The procedure utilizes the ECHELON™ 3000 stapler without any additional reinforcement. This means the staple lines are created using the standard stapler without the use of bioabsorbable buttress materials.~The ECHELON™ 3000 stapler is used to divide the lung parenchyma, pulmonary artery branches, veins, and bronchus without any reinforcement, relying solely on the standard stapling mechanism.
Study NCT05884645 — intervention group
Intervention type: PROCEDURE
Intervention: Video-directed endotracheal intubation
Description: There will be no intervention in this prospective observational cohort study. Endotracheal intubation is already used to secure the airway by placing an endotracheal tube into the trachea via the oral or nasal route. Indications include the need for airway control during general anaesthesia, mechanical ventilation, resuscitation, and various forms of acute respiratory distress.
Study NCT06704737 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AR training
Description: Dichoptic augmented reality training with dual-pathway (parvocellular pathway and magnocellular pathway) and interocular push-pull paradigms developed based on neural deficits in adults with unilateral amblyopia
Study NCT06704737 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Patching
Description: Conventional patching therapy.
Study NCT06704893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASA injection 40 mg group
Description: Participants will receive intra-articular knee injections under ultrasound guidance with AMNIOGEN® 40mg (HCT Regenerative, New Taipei, Taiwan) diluted in 3.0 mL of sterile normal saline.
Study NCT06704893 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASA injection 20 mg group
Description: Participants will receive intra-articular knee injections under ultrasound guidance with AMNIOGEN® 20mg (HCT Regenerative, New Taipei, Taiwan) diluted in 3.0 mL of sterile normal saline.
Study NCT06704893 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HA injection group
Description: Participants will receive intra-articular knee injections under ultrasound guidance with 3 ml of HyLink (SEIKAGAKU CORPORATION, Tokyo, Japan).
Study NCT06704893 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline injection group
Description: Participants will receive intra-articular knee injections under ultrasound guidance with 3 ml of sterile normal saline.
Study NCT06706583 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telematic educational interviews + standard training
Description: Physicians attending at healthcare centers in the experimental arm will receive periodic telematic educational interviews in which an Infectious Diseases consultant will provide practical training on the appropriate use of antibiotics through the review of one of the physician´s randomly chosen antibiotic prescription, according to a structured brief interview.~In addition to this, each of these centres will continue carrying out the already established activities of the Regional ASP (PIRASOA).
Study NCT06706583 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard training
Description: Primary Care Health Centers assigned to the control group will receive standard educational activities designated by the current Regional ASP (PIRASOA).
Study NCT06706050 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Microbiome Therapeutic LP-51
Description: Microbiome therapeutics LP-51 was applied on the individuals suffering from xerosis
Study NCT06706050 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo cream (M23004-03)
Description: placebo cream (M23004-03) was applied on the participants
Study NCT06704698 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Description: Thoracic paravertebral block with liposomal bupivacaine.
Study NCT06704698 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Bupivacaine Hydrochloride
Description: Epidural block with plane bupivacaine.
Study NCT06705400 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multi-behavioural
Description: The Bloom Study is implemented in an existing and highly accepted health service delivered by community health nurses. Beyond focusing on food, meals, motor skills and movement, the intervention also target sleep and family sense of security. The intervention commence in pregnancy and continues until the child is 2½ years old.
Study NCT06706349 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: APA managed by qualified instructor
Description: Each session will be led by a qualified APA professional and will include a mix of aerobic, anaerobic, and 'mind-body' activities like yoga, tailored to participant preferences. Intensity will range from moderate to vigorous, with activities such as walking, cycling, and club-based exercises for at least 20 minutes per session. Participants will be progressively involved in session planning to support continued practice post-study. Heart rate monitoring will be used during exercises like the 6-minute walk test and chair rise test, while a daily activity calendar will help ensure adherence, documenting session dates, durations, subjective intensity, and activity type.
Study NCT06706349 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Autonomous APA
Description: A leaflet highlighting the importance of non-sedentary behavior according to WHO recommendations will be provided to them. They will have the opportunity to engage in physical activity autonomously according to their preference.
Study NCT06706128 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: reflex rolling technique
Description: received reflex rolling technique for 20 min, 5 days a week, for 2 weeks.
Study NCT06706128 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: lung squeezing technique
Description: lung squeezing technique for 20 min, 5 days a week, for 2 weeks
Study NCT06705634 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry Needling
Description: A sterile, disposable, solid filament needle (Seirin Corp., Shizuoka, Japan) will be inserted manually into the multifidus of the C5-C6 cervical muscles. Once the needle has been inserted, the needle will be pistoned in an up and down motion within the multifidus muscle at approximately 1Hz for 10 seconds and then left in-situ for 5 minutes.
Study NCT06240260 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENS (transcutaneous electrical nerve stimulation) unit
Description: Transcutaneous electrical nerve stimulation (TENS) is a method of pain relief involving the use of a mild electrical current.~A TENS machine is a small, battery-operated device that has leads connected to sticky pads called electrodes.
Study NCT06240260 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard care
Description: Paracervical block only or participant declines analgesia for IUD insertion
Study NCT06056596 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamivudine 300 MG
Description: Drug to be taken once daily for three days (two days prior to surgery and on the morning of surgery)
Study NCT06056596 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Dose to be taken once daily for three days (two days prior to surgery and on the morning of surgery)
Study NCT05550779 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mental Exercise
Description: Participant perform a 10-minute mental exercise
Study NCT05550779 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mental Exercise
Description: Participant perform a 10-minute mental exercise
Study NCT05183178 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prasugrel 10 mg p.o
Description: Prasugrel 10 mg once daily p.o. Patient >75 years of age or \<60 kg will receive 5 mg prasugrel OD.
Study NCT05183178 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ticagrelor 90 mg
Description: Ticagrelor 90 mg twice daily p.o.
Study NCT04935658 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hypnotic relaxation induced by virtual reality (device)
Description: A virtual reality device will be install on the patient 3-5 minutes before the beginning of the oocyte retrieval. The device will be wearing by the patient during the entire intervention and 2 minutes after the end of the ponction.
Study NCT04935658 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: local anesthesia
Description: standard anesthesic procedure
Study NCT04935658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: local anesthesia
Description: standard anesthesic procedure
Study NCT05036096 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CBBCT Imaging
Description: Both breasts will be scanned by CBBCT. Only one breast will be scanned if the patient had mastectomy.
Study NCT05036096 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital Mammography
Description: Both breasts will take digital mammography standard views (CC, MLO) Only one breast will take digital mammography standard views if the patient had mastectomy.
Study NCT06456567 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Telitacicept
Description: Subcutaneous injection
Study NCT06456567 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subcutaneous injection
Study NCT06605495 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: fumigation with Chinese medicine
Description: Eye fumigation with the Eyesight Eye Therapy,10 minutes once daily for 6 weeks.